<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head><title>R: pancreatic</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link rel="stylesheet" type="text/css" href="R.css" />
</head><body><div class="container">

<table width="100%" summary="page for pancreatic"><tr><td>pancreatic</td><td style="text-align: right;">R Documentation</td></tr></table>

<h2>pancreatic

</h2>

<h3>Description</h3>

<p>Data from a Phase II clinical trial of patients with locally advanced or metastatic pancreatic cancer.
</p>


<h3>Usage</h3>

<pre>data("pancreatic")</pre>


<h3>Format</h3>

<p>A data frame with 41 observations on the following 4 variables.
</p>

<dl>
<dt><code>stage</code></dt><dd><p>a factor with levels <code>LA</code> (locally advanced) or <code>M</code> (metastatic)</p>
</dd>
<dt><code>onstudy</code></dt><dd><p>date of enrollment into the clinical trial, in month/day/year format</p>
</dd>
<dt><code>progression</code></dt><dd><p>date of progression, in month/day/year format</p>
</dd>
<dt><code>death</code></dt><dd><p>date of death, in month/day/year format</p>
</dd>
</dl>



<h3>Details</h3>

<p>Since all patients in this study have known death dates, there is no censoring.
</p>


<h3>References</h3>

<p>Moss RA, Moore D, Mulcahy MF, Nahum K, Saraiya B, Eddy S, Kleber M, and Poplin EA (2012)
A multi-institutional phase 2 study of imatinib mesylate and gemcitabine for first-line treatment of advanced pancreatic cancer. Gastrointestinal Cancer Research 5, 77 - 83.
</p>


<h3>Examples</h3>

<pre>
data(pancreatic)

</pre>


</div></body></html>
